134 related articles for article (PubMed ID: 35773121)
21. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
[TBL] [Abstract][Full Text] [Related]
22. Porcine circovirus type 2 (PCV2) vaccination reduces PCV2 in a PCV2 and Salmonella enterica serovar Choleraesuis coinfection model.
Takada-Iwao A; Seki M; Nakanishi M; Souma J; Okuda S; Okuda Y; Imai Y; Sato S
Vet Microbiol; 2013 Feb; 162(1):219-23. PubMed ID: 23107657
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis.
Li PC; Qiao XW; Zheng QS; Hou JB
Vaccine; 2016 Jan; 34(5):696-702. PubMed ID: 26372858
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity Evaluation of Modified Adenovirus Vaccines Expressing Porcine Circovirus Type 2 Capsid Protein in Pigs.
Li D; Xu D; Wang Z; Du Q; Chang L; Zhao X; Huang Y; Tong D
Viral Immunol; 2017 Mar; 30(2):111-119. PubMed ID: 27996636
[TBL] [Abstract][Full Text] [Related]
25. Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine.
He Q; Cao Z; Wang P; Lu Q; Zheng H; Sun J
Arch Virol; 2020 Oct; 165(10):2301-2309. PubMed ID: 32757056
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs.
Li D; Du Q; Wu B; Li J; Chang L; Zhao X; Huang Y; Tong D
Vaccine; 2017 Aug; 35(36):4722-4729. PubMed ID: 28755834
[TBL] [Abstract][Full Text] [Related]
27. Oral Immunization with Attenuated
Zhou G; Tian Y; Tian J; Ma Q; Huang S; Li Q; Wang S; Shi H
Microbiol Spectr; 2022 Dec; 10(6):e0236122. PubMed ID: 36377878
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
Jung BK; Kim HR; Lee YH; Jang H; Chang KS
J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
[TBL] [Abstract][Full Text] [Related]
29. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.
Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A
BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652
[TBL] [Abstract][Full Text] [Related]
30. PCV cap proteins fused with calreticulin expressed into polymers in Escherichia coli with high immunogenicity in mice.
Liu C; Liu Y; Feng H; Zhao B; Chen Y; Huang H; Wang P; Deng R; Zhang G
BMC Vet Res; 2020 Aug; 16(1):313. PubMed ID: 32854700
[TBL] [Abstract][Full Text] [Related]
31. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
[TBL] [Abstract][Full Text] [Related]
32. Encapsidated-CpG ODN enhances immunogenicity of porcine circovirus type 2 virus-like particles.
Hansoongnern P; Phecharat N; Wasanasuk K; Tommeurd W; Chankeeree P; Lekcharoensuk C; Semkum P; Pinitkiatisakul S; Lekcharoensuk P
Vet Microbiol; 2022 Dec; 275():109583. PubMed ID: 36332299
[TBL] [Abstract][Full Text] [Related]
33. Efficient production of porcine circovirus virus-like particles using the nonconventional yeast Kluyveromyces marxianus.
Duan J; Yang D; Chen L; Yu Y; Zhou J; Lu H
Appl Microbiol Biotechnol; 2019 Jan; 103(2):833-842. PubMed ID: 30421111
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
[TBL] [Abstract][Full Text] [Related]
35. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
[TBL] [Abstract][Full Text] [Related]
36. Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli.
Yin S; Sun S; Yang S; Shang Y; Cai X; Liu X
Virol J; 2010 Jul; 7():166. PubMed ID: 20646322
[TBL] [Abstract][Full Text] [Related]
37. Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a conserved surface protein enolase induces high and broad protection against Streptococcus suis serotypes 2, 7, and 9 in mice.
Li Q; Lv Y; Li YA; Du Y; Guo W; Chu D; Wang X; Wang S; Shi H
Vaccine; 2020 Oct; 38(44):6904-6913. PubMed ID: 32907758
[TBL] [Abstract][Full Text] [Related]
38. Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface.
Wang D; Zhang S; Zou Y; Yu W; Jiang Y; Zhan Y; Wang N; Dong Y; Yang Y
Front Cell Infect Microbiol; 2018; 8():232. PubMed ID: 30038901
[TBL] [Abstract][Full Text] [Related]
39. CD40 Ligand and GMCSF Coexpression Enhance the Immune Responses and Protective Efficacy of PCV2 Adenovirus Vaccine.
Li D; Huang Y; Du Q; Wang Z; Chang L; Zhao X; Tong D
Viral Immunol; 2016 Apr; 29(3):148-58. PubMed ID: 26982652
[TBL] [Abstract][Full Text] [Related]
40. Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.
Li W; Wang X; Bai J; Ma T; Li Z; Li Y; Jiang P
Vet Microbiol; 2013 Apr; 163(1-2):23-32. PubMed ID: 23294858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
